BRIEF published on 11/18/2024 at 08:05, 5 days 1 hour ago SEGRO's Offer for Tritax EuroBox Lapses Tritax EuroBox SEGRO Scheme Of Arrangement Acquisition Lapse Mini Long Stop Date
PRESS RELEASE published on 11/18/2024 at 08:00, 5 days 1 hour ago LAPSE OF SEGRO'S OFFER FOR TRITAX EUROBOX PLC SEGRO PLC announces lapse of offer for Tritax EuroBox PLC. Offer for entire share capital lapsed; Mini Long Stop Date condition invoked SEGRO PLC Tritax EuroBox Plc Mini Long Stop Date Offer Lapse Court-sanctioned Scheme
BRIEF published on 11/12/2024 at 08:05, 11 days 1 hour ago SEGRO's Strategic Moves Amid Tritax EuroBox Offer Lapse Investment Strategy Property Portfolio Tritax EuroBox SEGRO Offer Brookfield Agreement
PRESS RELEASE published on 11/12/2024 at 08:00, 11 days 1 hour ago UPDATE ON SEGRO PLC OFFER FOR TRITAX EUROBOX PLC SEGRO PLC's final offer for Tritax EuroBox PLC expected to lapse on 15 November 2024. SEGRO enters agreement to purchase German and Dutch companies from Tritax EuroBox for €470 million Acquisition Property Portfolio SEGRO PLC Tritax EuroBox Plc Final Offer
BRIEF published on 10/31/2024 at 12:05, 22 days 21 hours ago SEGRO's Updated Voting Rights Information Voting Rights London Stock Exchange Shares Regulatory Disclosure SEGRO
PRESS RELEASE published on 10/31/2024 at 12:00, 22 days 21 hours ago Total Voting Rights Press release detailing total number of voting rights and shares as per the French commercial code and AMF regulations Voting Rights French Commercial Code Shares Press Release AMF Regulations
BRIEF published on 10/28/2024 at 13:10, 25 days 20 hours ago SEGRO PLC Amends Public Opening Position Disclosure Position Disclosure Takeover Code SEGRO PLC Directors' Interests Connected Advisers
PRESS RELEASE published on 10/28/2024 at 13:05, 25 days 20 hours ago AMENDED PUBLIC OPENING POSITION DISCLOSURE SEGRO PLC discloses amended public opening position per Takeover Code. Form details ownership positions, interests, and directors' shares. Disclosures made to Regulatory Information Service under Rule 8 Takeover Code Disclosures SEGRO PLC Ownership Positions Regulatory Information Service
BRIEF published on 10/17/2024 at 16:05, 1 month 5 days ago SEGRO Issues 1,815 Shares Following Options Exercise Shares Issuance Rule 2.9 Disclosure Requirements SEGRO City Code
PRESS RELEASE published on 10/17/2024 at 16:00, 1 month 5 days ago Rule 2.9 Announcement SEGRO issued 1,815 Ordinary Shares under Sharesave plan. Current total: 1,352,858,805 Ordinary Shares. ISIN: GB00B5ZN1N88. Dealing Disclosure Requirements explained London Stock Exchange Ordinary Shares SEGRO PLC Sharesave Plan Dealing Disclosure Requirements
Published on 11/22/2024 at 23:55, 9 hours 28 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 53 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 18 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 53 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 29 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 27 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 23 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
